Traws Pharma, Inc.
Q3 2024 13F Holders
Symbol
TRAW
CUSIP
68232V884
Type
Equity
Class
COM NEW
Num filings
12
Total reported value, excl. options
$3.80 M
Compare 2024 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
2025 Q2
2025 Q1
2024 Q4
Manager
Report Date
Value ($000)
Shares
Option Type